LAVA Therapeutics NV (LVTX) — Cash Flow Quality Index

Latest as of September 2022: -14.59x

LAVA Therapeutics NV (LVTX) has a Cash Flow Quality Index of -14.59x as of September 2022. Operating cash flow of $-14.34 Million is below net income of $983.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore LAVA Therapeutics NV (LVTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-14.59x

Operating CF / Net Income

Operating Cash Flow

$-14.34 Million

USD

Net Income

$983.00K

USD

Data as of

Sep 2022

Most recent filing

Annual Cash Flow Quality Index for LAVA Therapeutics NV (None–None)

Year-by-year earnings quality comparison for LAVA Therapeutics NV.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.